NAPOLEONVILLE, LA / ACCESSWIRE / April 18, 2024 / Impact Fusion International Inc. ("The Company") (OTC PINK:IFUS) is pleased to report that Mr. Robert (Trey) Schmidt III has agreed to join the ...

DividendPharmaSGP Holding SE proposes an increased dividend of EUR 1.36 per share for 202318-Apr-2024 / 20:31 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) ...

NORTHAMPTON, MA / ACCESSWIRE / April 18, 2024 / Gilead Sciences published its 2023 Environmental, Social and Governance (ESG) Impact Report, which uses the ESG framework to highlight the successes and ...

Tereos, a leading global player in the sugar, alcohol and starch market, announce the opening of its new Customer Innovation Centre located in Aalst, Belgium. This cutting-edge facility is designed to ...

Medincell enters into strategic co-development and licensing agreement with AbbVie to develop next-generation long-acting injectable therapies Euronext: MEDCL - Montpellier - France – April 16, 2024 - ...

April 17, 2024 – Servier, an independent international pharmaceutical group, announces the following appointments to the Group's Executive Committee:·    Charlotte Marmousez-Tartar as Executive Vice ...

Xeltis Announces Latest Results from aXess Trials to be Presented at 46th Annual Charing Cross Symposium Two key presentations by leading KOLs highlight positive results from aXess trials in adult ...

NEWS RELEASELucida Medical LtdBlackford and Lucida Medical Partner to Enhance Prostate CareFOR IMMEDIATE RELEASEEdinburgh, Scotland (April 17, 2024) - Blackford, the pioneering strategic AI platform ...

A novel approach to drug discovery is enabling University of Birmingham researchers to overcome the ‘valley of death’, where projects fail due to the funding gap between original research and ...

New 4Advanced technology and support to enable the development of GenAI solutionsBARCELONA, Spain — 18 April 2024 — Veeva Systems (NYSE: VEEV) today announced the Veeva AI Partner Program to provide ...

Polaroid Therapeutics, a Swiss-based biotech start-up, today announces the appointment of Markus Rothmaier as its inaugural Head of Research and Development (R&D). With over two decades of ...

IB CommunicationsTel +44 (0)20 89434685likarda@ibcomms.agency Likarda appoints Shelly Adams as Chief Commercial Officer Kansas City, USA, April 17, 2024 – Likarda, a leading biotech company ...